Armstrong Pharmaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 25 John Road, Canton, Massachusetts (MA) 02021, United States (USA)
- Operations here
- analysisdistributelabelmanufacturepackparticle size reduction
- FDA identifiers
- FEI 3007009553 · DUNS 809773794
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-05-08
- VAIBioresearch Monitoring2024-07-19
- NAIDrug Quality Assurance2021-07-14
- NAIDrug Quality Assurance2014-04-03
- NAIDrug Quality Assurance2012-10-05
- VAIDrug Quality Assurance2012-06-14
- NAIDrug Quality Assurance2009-12-11
- VAIDrug Quality Assurance2009-11-13
- VAIBioresearch Monitoring2009-09-29
- VAIDrug Quality Assurance2008-12-30
- NAIDrug Quality Assurance2008-10-16
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- Ipratropium Bromide InhalationArmstrong Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.